1. Lung Transplantation and Coronary Artery Disease
William Sherman, MD, David G. Rabkin, MD, David Ross, MD, Rajan Saggar, MD, Joseph P. Lynch, MD, John Belperio, MD, Rajeev Saggar, MD, Michele Hamilton, MD, Abbas Ardehali, MD 
The Annals of Thoracic Surgery 
Volume 92, Issue 1, Pages (July 2011)
DOI: /j.athoracsur
Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

2. Fig 1
Coronary revascularization protocol among the accepted lung transplant candidates with coronary artery disease. († = criteria for acceptance of lung transplant candidates with CAD: discrete coronary artery lesions with preserved ventricular function who are otherwise acceptable candidates. * = criteria for single lung transplantation: age > 60, no evidence of septic lung disease, and [or] pulmonary hypertension; CABG = coronary artery bypass grafting; CAD = coronary artery disease; PCI = percutaneous coronary intervention.)
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

3. Fig 2
The survival curves of lung transplant recipients with CAD and the control group were similar up to 5 years posttransplantation. (--- = coronary artery disease [CAD] group; — = control group.)
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions